NCT07181473
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07181473
Title A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Phrontline Biopharma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists & Research Institute RECRUITING Orlando Florida 32827 United States Details
Sarah Cannon Research Institute (SCRI) RECRUITING Nashville Tennessee 37203 United States Details
Oncology Consultants RECRUITING Houston Texas 77030 United States Details
Henan Cancer Hospital NOT_YET_RECRUITING Zhengzhou Henan China Details
Union Hospital of Tongji Medical College NOT_YET_RECRUITING Wuhan Hubei China Details
Sir Run Run Shaw Hospital NOT_YET_RECRUITING Hangzhou Zhejiang China Details
Shanghai East Hospital RECRUITING Shanghai China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field